Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

INTRODUCTION: This study assessed if concomitant use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib in rheumatoid arthritis (RA) patients. METHODS: Patients with ≥ 6 swollen/tender joints and no pri...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Rheumatol Ther
Huvudupphovsmän: van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Healthcare 2018
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251844/
https://ncbi.nlm.nih.gov/pubmed/30357613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0128-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk